Hans G. Van Der Hoeven-Van Der Voet

Godesberger Allee 64
Bonn, NW 53175, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Journal: European urology

Published: December 23, 2025

Immediate vs Delayed Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: 5-Year Outcomes From the COACT Randomized Trial.

Immediate vs Delayed Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: 5-Year Outcomes From the COACT Randomized Trial.

Journal: Journal of the American College of Cardiology

Published: October 13, 2025

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.

Journal: The Lancet. Oncology

Published: December 20, 2024

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.

Journal: The New England journal of medicine

Published: October 16, 2024

The interplay between organizational culture and burnout among ICU professionals: A cross-sectional multicenter study.

The interplay between organizational culture and burnout among ICU professionals: A cross-sectional multicenter study.

Journal: Journal of critical care

Published: September 27, 2024

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.

Journal: European urology

Published: April 18, 2024

Evaluating the use of casuistry during moral case deliberation in the ICU: A multiple qualitative case study.

Evaluating the use of casuistry during moral case deliberation in the ICU: A multiple qualitative case study.

Journal: Social science & medicine (1982)

Published: October 06, 2023

The Prognostic Value of Troponin-T in Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A COACT Substudy.

The Prognostic Value of Troponin-T in Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A COACT Substudy.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions

Published: July 14, 2023

Consensus-based indicators for evaluating and improving the quality of regional collaborative networks of intensive care units: Results of a nationwide Delphi study.

Consensus-based indicators for evaluating and improving the quality of regional collaborative networks of intensive care units: Results of a nationwide Delphi study.

Journal: Journal of critical care

Published: May 23, 2023

Different perspectives of ethical climate and collaboration between ICU physicians and nurses.

Different perspectives of ethical climate and collaboration between ICU physicians and nurses.

Journal: Intensive care medicine

Published: March 24, 2023

Development of Moral Injury in ICU Professionals During the COVID-19 Pandemic: A Prospective Serial Interview Study.

Development of Moral Injury in ICU Professionals During the COVID-19 Pandemic: A Prospective Serial Interview Study.

Journal: Critical care medicine

Published: January 20, 2023

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

Journal: The Lancet. Oncology

Published: May 31, 2022

Showing 1-12 of 70

Last Updated: 09/26/2026